DK0669129T3 - Ekspanderbare lægemiddelformer med kontrolleret afgivelse af aktivt stof - Google Patents
Ekspanderbare lægemiddelformer med kontrolleret afgivelse af aktivt stofInfo
- Publication number
- DK0669129T3 DK0669129T3 DK95102074T DK95102074T DK0669129T3 DK 0669129 T3 DK0669129 T3 DK 0669129T3 DK 95102074 T DK95102074 T DK 95102074T DK 95102074 T DK95102074 T DK 95102074T DK 0669129 T3 DK0669129 T3 DK 0669129T3
- Authority
- DK
- Denmark
- Prior art keywords
- contg
- polymer
- pref
- gps
- polymers
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4406424A DE4406424A1 (de) | 1994-02-28 | 1994-02-28 | Expandierbare Arzneiformen |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0669129T3 true DK0669129T3 (da) | 2002-02-25 |
Family
ID=6511366
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK95102074T DK0669129T3 (da) | 1994-02-28 | 1995-02-15 | Ekspanderbare lægemiddelformer med kontrolleret afgivelse af aktivt stof |
Country Status (10)
Country | Link |
---|---|
US (2) | US5651985A (ja) |
EP (1) | EP0669129B1 (ja) |
JP (1) | JP3937464B2 (ja) |
AT (1) | ATE207741T1 (ja) |
CA (1) | CA2143500C (ja) |
DE (2) | DE4406424A1 (ja) |
DK (1) | DK0669129T3 (ja) |
ES (1) | ES2166790T3 (ja) |
PT (1) | PT669129E (ja) |
SI (1) | SI0669129T1 (ja) |
Families Citing this family (65)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4406424A1 (de) * | 1994-02-28 | 1995-08-31 | Bayer Ag | Expandierbare Arzneiformen |
FR2723536A1 (fr) * | 1994-08-11 | 1996-02-16 | Seth Pawan | Composition permettant une liberation selective d'un principe actif |
US6280745B1 (en) | 1997-12-23 | 2001-08-28 | Alliance Pharmaceutical Corp. | Methods and compositions for the delivery of pharmaceutical agents and/or the prevention of adhesions |
PT936903E (pt) * | 1996-09-07 | 2004-03-31 | Gunther Beisel | Agente de efeito retardador |
JP3825811B2 (ja) * | 1997-01-14 | 2006-09-27 | エルティエス ローマン テラピー−ズュステーメ アーゲー | 胃腸系での活性物質の制御放出を用いた膨張性胃内貯留治療システム |
SE9702533D0 (sv) | 1997-07-01 | 1997-07-01 | Astra Ab | New oral formulation |
IN186245B (ja) | 1997-09-19 | 2001-07-14 | Ranbaxy Lab Ltd | |
US6090411A (en) * | 1998-03-09 | 2000-07-18 | Temple University | Monolithic tablet for controlled drug release |
FR2784583B1 (fr) | 1998-10-16 | 2002-01-25 | Synthelabo | Composition pharmaceutique a residence gastrique et a liberation controlee |
DE19920833A1 (de) * | 1999-05-06 | 2000-11-16 | Lohmann Therapie Syst Lts | Gastroretentives System mit quellbaren Polymeren |
FR2797185B1 (fr) * | 1999-08-06 | 2001-10-26 | Galenix Dev | Composition pharmaceutique flottante comprenant une phase active et une phase non active |
IL133196A0 (en) | 1999-11-29 | 2001-03-19 | Yissum Res Dev Co | Gastroretentive controlled release pharmaceutical dosage forms |
EP1118321A1 (fr) * | 2000-01-14 | 2001-07-25 | Ucb, S.A. | Compositions pharmaceutiques solides pour la libération contrôlée de substances actives |
IL150850A0 (en) * | 2000-02-10 | 2003-02-12 | Bpsi Holdings Inc | Enteric coating compositions containing acrylic resin |
BR0108958A (pt) * | 2000-03-03 | 2003-09-30 | Ranbaxy Lab Ltd | Sistema de liberação controlada, administrado oralmente, para administração diária de ciprofloxacina |
DE10014588A1 (de) | 2000-03-27 | 2001-10-04 | Basf Ag | Wirkstoffhaltige Schwimmformen enthaltend Polyvinylacetat und Polyvinylpyrrolidon, deren Verwendung und Herstellung |
DE10031043A1 (de) * | 2000-06-26 | 2002-02-14 | Bayer Ag | Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung |
EP1245227A1 (en) | 2001-03-31 | 2002-10-02 | Jagotec Ag | A pharmaceutical tablet system that floats in the stomach for programmed release of active substance and process of producing buoyant material contained in same |
AU2008255254B2 (en) * | 2001-03-31 | 2010-12-09 | Jagotec Ag | A pharmaceutical tablet system that floats on gastric fluid for multipulse release of active substance and respective processes of producing same and a cup-shaped envelope of same |
PL370793A1 (en) * | 2001-07-04 | 2005-05-30 | Sun Pharmaceutical Industries Limited | Gastric retention controlled drug delivery system |
US20040219186A1 (en) * | 2001-08-16 | 2004-11-04 | Ayres James W. | Expandable gastric retention device |
BR0117123A (pt) * | 2001-08-16 | 2004-09-28 | Oregon State | Dispositivo de retenção gástrica expansìvel |
US20030104052A1 (en) * | 2001-10-25 | 2003-06-05 | Bret Berner | Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract |
US20030091630A1 (en) * | 2001-10-25 | 2003-05-15 | Jenny Louie-Helm | Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data |
US7612112B2 (en) | 2001-10-25 | 2009-11-03 | Depomed, Inc. | Methods of treatment using a gastric retained gabapentin dosage |
TWI312285B (en) | 2001-10-25 | 2009-07-21 | Depomed Inc | Methods of treatment using a gastric retained gabapentin dosage |
CA2409552A1 (en) | 2001-10-25 | 2003-04-25 | Depomed, Inc. | Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract |
US20030152622A1 (en) * | 2001-10-25 | 2003-08-14 | Jenny Louie-Helm | Formulation of an erodible, gastric retentive oral diuretic |
EP1509208A1 (en) * | 2002-02-04 | 2005-03-02 | Ranbaxy Laboratories Limited | Hydrodynamically balancing oral drug delivery system with biphasic release |
US7923032B2 (en) * | 2002-11-26 | 2011-04-12 | Seacoast Neuroscience, Inc. | Buoyant polymer particles for delivery of therapeutic agents to the central nervous system |
TWI355276B (en) * | 2003-01-14 | 2012-01-01 | Akira Tsuji | Gastrointestinal absorption enhancer mediated by p |
TW200533391A (en) | 2004-03-25 | 2005-10-16 | Sun Pharmaceutical Ind Ltd | Gastric retention drug delivery system |
US20050220873A1 (en) * | 2004-04-02 | 2005-10-06 | Chien-Hsuan Han | Pharmaceutical dosage forms having immediate and controlled release properties that contain a GABAB receptor agonist |
US20050220863A1 (en) * | 2004-04-02 | 2005-10-06 | Chien-Hsuan Han | Pharmaceutical dosage forms having controlled release properties that contain a GABAB receptor agonist |
US20050226927A1 (en) * | 2004-04-02 | 2005-10-13 | Impax Laboratories, Inc. | Pharmaceutical dosage forms having immediate release and/or controlled release properties that contain a GABAB receptor agonist |
US8007827B2 (en) * | 2004-04-02 | 2011-08-30 | Impax Laboratories, Inc. | Pharmaceutical dosage forms having immediate release and/or controlled release properties |
DE102004023069A1 (de) | 2004-05-11 | 2005-12-08 | Bayer Healthcare Ag | Neue Darreichungsformen des PDE 5-Inhibitors Vardenafil |
US20050287212A1 (en) * | 2004-06-28 | 2005-12-29 | Liang-Chang Dong | Oral delivery system comprising a drug/polymer complex |
US20090176882A1 (en) | 2008-12-09 | 2009-07-09 | Depomed, Inc. | Gastric retentive gabapentin dosage forms and methods for using same |
CA2647487C (en) * | 2006-03-29 | 2014-10-21 | Electronic Dietary Foods Inc. | Ingestible implement for weight control |
US9579227B2 (en) | 2006-03-29 | 2017-02-28 | Eat Little Inc. | Ingestible implement for weight control |
US8426466B2 (en) | 2006-05-22 | 2013-04-23 | Nexus Pharma, Inc. | Compositions and methods for enhancing active agent absorption |
US8889184B2 (en) * | 2006-09-07 | 2014-11-18 | Losan Pharma Gmbh | Particulate form of a pharmaceutical composition which is easy to swallow |
WO2009008873A1 (en) * | 2007-07-06 | 2009-01-15 | Basf Corporation | A gastroretentive composition on the basis of a water-soluble reaction product from a vinyl group- containing precursor |
CA2694602A1 (en) * | 2007-07-27 | 2009-02-05 | Depomed, Inc. | Pulsatile gastric retentive dosage forms |
US20090036414A1 (en) * | 2007-08-02 | 2009-02-05 | Mutual Pharmaceutical Company, Inc. | Mesalamine Formulations |
US20110171275A1 (en) * | 2007-08-20 | 2011-07-14 | Team Academy Of Pharmaceutical Science | Gastroretentive drug delivery system, preparation method and use thereof |
MX340249B (es) | 2008-08-15 | 2016-07-01 | Depomed Inc | Composiciones farmacéuticas retentivas gástricas para tratamiento y prevención de transtornos del sistema nervioso central (cns). |
KR20110042366A (ko) | 2008-08-18 | 2011-04-26 | 팀 아카데미 오브 파마슈티컬 사이언스 | 위장체류 약물 전달 시스템, 제작 방법 및 그것들의 사용 |
EP2210585A1 (en) | 2009-01-16 | 2010-07-28 | Exelgyn | SPRM pharmaceutical compositions methods of treatment using them |
US8858963B1 (en) | 2011-05-17 | 2014-10-14 | Mallinckrodt Llc | Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia |
US8658631B1 (en) | 2011-05-17 | 2014-02-25 | Mallinckrodt Llc | Combination composition comprising oxycodone and acetaminophen for rapid onset and extended duration of analgesia |
WO2013051036A1 (en) | 2011-10-03 | 2013-04-11 | Council Of Scientific & Industrial Research | Use of pharmaceutical composition for gastroretentive sustained and pulsatile drug delivery system |
US20130143867A1 (en) | 2011-12-02 | 2013-06-06 | Sychroneuron Inc. | Acamprosate formulations, methods of using the same, and combinations comprising the same |
JP2016520653A (ja) | 2013-06-05 | 2016-07-14 | シンクロニューロン インコーポレイテッド | アカンプロサート製剤、それを用いる方法、およびそれを含む合剤 |
FR3014692B1 (fr) * | 2013-12-18 | 2016-01-29 | Ethypharm Sa | Compositions pharmaceutiques orales a retention gastrique. |
PL235144B1 (pl) | 2014-06-03 | 2020-06-01 | Univ Medyczny Im Piastow Slaskich We Wroclawiu | Sposób wytwarzania tabletki flotacyjnej o przedłużonym oddziaływaniu substancji leczniczych z błoną śluzową żołądka oraz kompozycja farmaceutyczna |
US20170266112A1 (en) | 2014-06-11 | 2017-09-21 | Massachusetts Institute Of Technology | Residence structures and related methods |
CN106714893B (zh) | 2014-06-11 | 2021-01-01 | 麻省理工学院 | 自组装的驻留装置及相关方法 |
WO2017070612A1 (en) * | 2015-10-23 | 2017-04-27 | Lyndra, Inc. | Gastric residence systems for sustained release of therapeutic agents and methods of use thereof |
CN108697649A (zh) | 2015-12-08 | 2018-10-23 | 林德拉有限公司 | 用于胃驻留系统的几何构型 |
BR112019003811A2 (pt) | 2016-08-26 | 2019-05-21 | Exciva Ug (Haftungsbeschränkt) | composição farmacêutica, método para aumentar os níveis plasmáticos de antagonista do receptor de nmda em um sujeito que precisa do mesmo, método para tratar uma doença ou transtorno em um sujeito que precisa do mesmo e uso da composição |
CA3038557A1 (en) | 2016-09-30 | 2018-04-05 | Lyndra, Inc. | Gastric residence systems for sustained delivery of adamantane-class drugs |
CN110996906A (zh) | 2017-06-09 | 2020-04-10 | 林德拉有限公司 | 具有调节释放速度的膜的胃驻留系统 |
WO2023214018A1 (en) * | 2022-05-06 | 2023-11-09 | Galenix Innovations | Gastro-retentive swellable sustained release composition |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3458622A (en) * | 1967-04-07 | 1969-07-29 | Squibb & Sons Inc | Controlled release tablet |
US3574820A (en) * | 1968-01-08 | 1971-04-13 | Upjohn Co | Medicinal dosage forms of unpolymerized thiolated gelatin with a cross-linking accelerating agent providing slowly released medication from a swollen matrix |
USRE27107E (en) * | 1968-05-01 | 1971-03-30 | Drug composition | |
US3634584A (en) * | 1969-02-13 | 1972-01-11 | American Home Prod | Sustained action dosage form |
JPS5512411B2 (ja) * | 1974-03-12 | 1980-04-02 | ||
JPS5276418A (en) * | 1975-12-19 | 1977-06-27 | Microbial Chem Res Found | Method of preparing foamable micro-capsule preparations |
US4167558A (en) * | 1976-02-13 | 1979-09-11 | Hoffmann-La Roche Inc. | Novel sustained release tablet formulations |
US4101650A (en) * | 1977-04-06 | 1978-07-18 | Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai | Pepstatin floating minicapsules |
US4434153A (en) * | 1982-03-22 | 1984-02-28 | Alza Corporation | Drug delivery system comprising a reservoir containing a plurality of tiny pills |
DE3314003A1 (de) * | 1983-04-18 | 1984-10-18 | Boehringer Ingelheim KG, 6507 Ingelheim | Teilbare tablette mit verzoegerter wirkstofffreigabe und verfahren zu deren herstellung |
JPS6248618A (ja) * | 1985-08-27 | 1987-03-03 | Zeria Shinyaku Kogyo Kk | 徐放性製剤およびその製造法 |
JPS62195323A (ja) * | 1986-02-24 | 1987-08-28 | Eisai Co Ltd | 胃内滞留型粒子 |
JPH0747534B2 (ja) * | 1986-06-02 | 1995-05-24 | ロ−ラ−ジヤパン株式会社 | 錠 剤 |
US4798725A (en) * | 1986-06-16 | 1989-01-17 | Norwich Eaton Pharmaceuticals, Inc. | Sustained release capsule |
US4971805A (en) * | 1987-12-23 | 1990-11-20 | Teysan Pharmaceuticals Co., Ltd. | Slow-releasing granules and long acting mixed granules comprising the same |
DE3803482A1 (de) * | 1988-02-05 | 1989-08-17 | Lohmann Therapie Syst Lts | Schwimmfaehiges orales therapeutisches system |
US5158777A (en) * | 1990-02-16 | 1992-10-27 | E. R. Squibb & Sons, Inc. | Captopril formulation providing increased duration of activity |
IT1250654B (it) * | 1991-07-08 | 1995-04-21 | Farcon Ag | Metodo per la preparazione di forme farmaceutiche orali a rilascio prolungato contenenti sostanze attive a solubilita' dipendente dal valore di ph. |
JPH0624959A (ja) * | 1991-10-04 | 1994-02-01 | Bayer Yakuhin Kk | 胃内浮遊型薬物徐放性固形製剤 |
US5167964A (en) * | 1992-02-14 | 1992-12-01 | Warner-Lambert Company | Semi-enteric drug delivery systems and methods for preparing same |
DE4406424A1 (de) * | 1994-02-28 | 1995-08-31 | Bayer Ag | Expandierbare Arzneiformen |
-
1994
- 1994-02-28 DE DE4406424A patent/DE4406424A1/de not_active Withdrawn
-
1995
- 1995-02-15 ES ES95102074T patent/ES2166790T3/es not_active Expired - Lifetime
- 1995-02-15 DK DK95102074T patent/DK0669129T3/da active
- 1995-02-15 SI SI9530489T patent/SI0669129T1/xx unknown
- 1995-02-15 AT AT95102074T patent/ATE207741T1/de not_active IP Right Cessation
- 1995-02-15 EP EP95102074A patent/EP0669129B1/de not_active Expired - Lifetime
- 1995-02-15 DE DE59509765T patent/DE59509765D1/de not_active Expired - Lifetime
- 1995-02-15 PT PT95102074T patent/PT669129E/pt unknown
- 1995-02-21 US US08/392,008 patent/US5651985A/en not_active Expired - Lifetime
- 1995-02-27 CA CA002143500A patent/CA2143500C/en not_active Expired - Lifetime
- 1995-02-28 JP JP06360195A patent/JP3937464B2/ja not_active Expired - Lifetime
-
1997
- 1997-05-09 US US08/854,048 patent/US6306439B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US5651985A (en) | 1997-07-29 |
JP3937464B2 (ja) | 2007-06-27 |
CA2143500A1 (en) | 1995-08-29 |
CA2143500C (en) | 2007-04-24 |
DE4406424A1 (de) | 1995-08-31 |
ATE207741T1 (de) | 2001-11-15 |
ES2166790T3 (es) | 2002-05-01 |
EP0669129A2 (de) | 1995-08-30 |
EP0669129A3 (de) | 1995-11-22 |
JPH0840879A (ja) | 1996-02-13 |
SI0669129T1 (en) | 2002-04-30 |
US6306439B1 (en) | 2001-10-23 |
PT669129E (pt) | 2002-03-28 |
DE59509765D1 (de) | 2001-12-06 |
EP0669129B1 (de) | 2001-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0669129T3 (da) | Ekspanderbare lægemiddelformer med kontrolleret afgivelse af aktivt stof | |
US4741872A (en) | Preparation of biodegradable microspheres useful as carriers for macromolecules | |
NO843237L (no) | Kryssbindende, poroese polymerer for kontrollert legemiddelavgivning | |
UA41873C2 (uk) | Композиція аерозолю, що знаходиться під тиском | |
EE02958B1 (et) | Prolongeeritud toimega preparaat, polümeeride segu selle valmistamiseks ja polümeeride segu valmistamismeetod | |
DK0744940T3 (da) | Medikamenter, vacciner og hormoner i polylactidovertrukne mikrokugler | |
CA2409828A1 (en) | Formulation based in heparin, glycosaminoglycan or heparinoid, use of the formulation and the formulation base | |
ATE108650T1 (de) | Methode und zusammensetzung zur oralen verabreichung von bioaktiven mitteln zur peyer's flecken. | |
ES2187086T3 (es) | Soluciones de acidos percarboxilicos que estabilizan la dureza, procedimiento para su preparacion y su utilizacion. | |
WO1995020610A3 (en) | Two-phase acidic aqueous compositions for diffusion transfer products | |
EP1138730A3 (en) | Aqueous polymer emulsions | |
ES2085918T3 (es) | Formulacion de tmb para hrp-elisa soluble y precipitable. | |
NO821357L (no) | Ny farmasoeytisk tilberedning. | |
FR2704752B1 (fr) | Composition cosmétique sous forme de gel aqueux. | |
DE59909717D1 (de) | Verfahren zur Herstellung von festen Dosierungsformen | |
RU2004117848A (ru) | Система продолжительного высвобождения растворимого лекарственного средства | |
ATE223197T1 (de) | Kosmetische oder pharmazeutische zusammensetzung enthaltend ein ester des dextrins und ein hydrophiles geliermittel | |
NZ333180A (en) | Topical aqueous gel composition containing a combination of a non-steroidal anti-inflammatory drug, a xanthine derivative, a gelling agent, water and a cosolvent | |
DE3880406D1 (de) | Vertraegliche polymermischungen (i). | |
BR9507270A (pt) | Processos de polimerização aquosa para a preparação de uma resina ou resinas termoplásticas e de radical livre para a preparação de uma resina termoplástica e composição de resina de polímero ou copolímero | |
JPS56133312A (en) | Production of aqueous dispersion of polymer | |
KR910004771A (ko) | 수용성 점착제 조성물 | |
KR880002907A (ko) | 고함수율 중합체의 제조방법 |